Company profile
Cure51
We want every patient to become a Cancer Survivor.
- Industry
- Biotechnology Research
- Employees
- 60
- Headquarters
- Paris
- Founded
- 2021
- Office locations
- 1
Cure51 company summary
Cure51 is a company in the Biotechnology Research industry, headquartered in Paris, founded in 2021. On LinkedIn the company has around 60 employees.
What technology does Cure51 use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About Cure51
Cure 51 is a TechBio aiming at creating the first ever worldwide database of Cancer Survivors. The company was co-created with leading oncology centres and has already identified more than 1500 survivors in 42 countries across all continents. The company has developed its own data collection and discovery platform as well as a dedicated Central Lab to proceed to a multiomic sequencing of the survivors’ samples. Through this approach, Cure51 will identify robust therapeutic targets, validated by its scientific community, in order to develop novel drugs to cure Cancer. The focus for Cure51 is initially to start with 3 types of particularly agressive cancers and will naturally expand to other indications and therapeutic areas to capitalize on its exclusive and unprecedented set of data and discovery pipelines.
Where is Cure51 located?
Cure51 lists 1 location.
Compare companies similar to Cure51
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
Cure51 cure51.com | Biotechnology Research | 60 | 2021 | Paris |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about Cure51
What does Cure51 do?
Cure 51 is a TechBio aiming at creating the first ever worldwide database of Cancer Survivors. The company was co-created with leading oncology centres and has already identified more than 1500 survivors in 42 countries across all continents. The company has developed its own data collection and discovery platform as well as a dedicated Central Lab to proceed to a multiomic sequencing of the survivors’ samples. Through this approach, Cure51 will identify robust therapeutic targets, validated by its scientific community, in order to develop novel drugs to cure Cancer. The focus for Cure51 is initially to start with 3 types of particularly agressive cancers and will naturally expand to other indications and therapeutic areas to capitalize on its exclusive and unprecedented set of data and discovery pipelines.
How many employees does Cure51 have?
Cure51 has around 60 employees on LinkedIn.
Where is Cure51 headquartered?
Cure51 is headquartered in Paris.
When was Cure51 founded?
Cure51 was founded in 2021.
Build a lead list from companies like Cure51
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.